APA

Su X., Song H., Niu F., Yang K., Kou G., Wang X., Chen H., Li W., Guo S., Li J., Li B., Feng S., Jiang J., Yin C. & Gao J. (20160421). Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance. : Nanomedicine (London, England).

Chicago

Su Xiao, Song Hao, Niu Fangfang, Yang Kaixuan, Kou Geng, Wang Xiaohang, Chen Huaiwen, Li Wei, Guo Shangjing, Li Jun, Li Bohua, Feng Si-Shen, Jiang Jianxin, Yin Chuan and Gao Jie. 20160421. Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance. : Nanomedicine (London, England).

Harvard

Su X., Song H., Niu F., Yang K., Kou G., Wang X., Chen H., Li W., Guo S., Li J., Li B., Feng S., Jiang J., Yin C. and Gao J. (20160421). Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance. : Nanomedicine (London, England).

MLA

Su Xiao, Song Hao, Niu Fangfang, Yang Kaixuan, Kou Geng, Wang Xiaohang, Chen Huaiwen, Li Wei, Guo Shangjing, Li Jun, Li Bohua, Feng Si-Shen, Jiang Jianxin, Yin Chuan and Gao Jie. Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance. : Nanomedicine (London, England). 20160421.